During the past decade, Trustees of the University of Pennsylvania conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Trustees of the University of Pennsylvania" #1 sponsor was "C. R. Bard" with 3 trials, followed by "Intuitive Surgical" with 1 trials sponsored, "Jaeb Center for Health Research" with 1 trials sponsored, "Michael J. Fox Foundation for Parkinson's Research" with 1 trials sponsored and "Ottawa Heart Institute Research Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Trustees of the University of Pennsylvania" #1 collaborator was "Indiana University" with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator, "National Institutes of Health (NIH)" with 1 trials as a collaborator and "University Health Network, Toronto" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Trustees of the University of Pennsylvania" are "Arteriovenous Fistula" (1 trials), "Ascending Aorta Aneurysm" (1 trials), "Ascending Aortic Aneurysm Enlargement" (1 trials), "Epiretinal Membrane" (1 trials) and "Incisional Hernia" (1 trials). Many other conditions were trialed in "Trustees of the University of Pennsylvania" in a lesser frequency.

Most popular intervention types in "Trustees of the University of Pennsylvania" are "Device" (4 trials), "Procedure" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Deferred Vitrectomy" (1 trials), "Immediate Vitrectomy" (1 trials), "Lumbar Puncture" (1 trials), "Lutonix DCB" (1 trials) and "PTA followed by placement of LifeStent® Vascular Stent" (1 trials). Other intervention names were less common.

The vast majority of trials in "Trustees of the University of Pennsylvania" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Trustees of the University of Pennsylvania". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Trustees of the University of Pennsylvania, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Trustees of the University of Pennsylvania, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".